Cerus Corporation has secured CE mark approval for its INT200, a LED-based illumination device, for the Intercept Blood ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

C Medical Technologies has closed its Series D financing round. which was led by Boston Scientific, raising gross proceeds of ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

Foresight Diagnostics has launched the PRECISE-HL trial, which will use the Foresight Clarity LDT to treat patients with ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...

Olympus is set to launch the Retentia HemoClip to assist gastrointestinal (GI) endoscopists in performing haemostasis.

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Epredia has received 510(k) clearance from the FDA for the E1000 Dx, a scanner designed to streamline laboratory cancer ...